Abstract
The effectiveness of clinical decision support (CDS) tools for selecting therapies in precision oncology is dependent on the flow of biomarker testing information through the electronic health record (EHR). The growth of biomarker-specific cancer treatments has contributed to an increasingly complex environment of testing choices and results for providers to navigate. The purpose of this study was to map biomarker information pathways for cancer treatment within an EHR. Specifically, the study used test reports, structured EHR data, and CDS tool records to measure and visualize the flow of biomarker data relative to critical treatment decisions made by providers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
